Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2026-01-13 @ 11:13 PM
Study NCT ID:
NCT02321592
Status:
COMPLETED
Last Update Posted:
2020-11-13
First Post:
2014-12-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GHSG-AFM13 An Open-label, Multicenter Phase II Trial With AFM13 in Patients With Relapsed or Refractory Hodgkin Lymphoma
Sponsor:
University of Cologne
Organization: